These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 25682993)

  • 81. Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab.
    Saigusa K; Matsuoka K; Sugimoto S; Arai M; Kiyohara H; Takeshita K; Mizuno S; Mori K; Nanki K; Takeshita T; Nakazato Y; Yajima T; Naganuma M; Hisamatsu T; Ogata H; Iwao Y; Kanai T
    Dig Endosc; 2016 Sep; 28(6):665-70. PubMed ID: 26997640
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy.
    Inoue T; Murano M; Narabayashi K; Okada T; Nouda S; Ishida K; Kawakami K; Abe Y; Takeuchi T; Tokioka S; Umegaki E; Higuchi K
    Intern Med; 2013; 52(1):15-20. PubMed ID: 23291669
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
    Cortes X; Borrás-Blasco J; Fernendez S; Moreno M; Rodríguez J; Molés JR; Casterá E
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):125-8. PubMed ID: 26754306
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study.
    Parente F; Molteni M; Marino B; Colli A; Ardizzone S; Greco S; Sampietro G; Foschi D; Gallus S
    Am J Gastroenterol; 2010 May; 105(5):1150-7. PubMed ID: 19997096
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis.
    Papamichael K; Van Stappen T; Vande Casteele N; Gils A; Billiet T; Tops S; Claes K; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):543-9. PubMed ID: 26681486
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients.
    Hiraoka S; Kato J; Moritou Y; Takei D; Inokuchi T; Nakarai A; Takahashi S; Harada K; Okada H; Yamamoto K
    BMC Gastroenterol; 2015 Apr; 15():53. PubMed ID: 25925267
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
    Ogata H; Matsui T; Nakamura M; Iida M; Takazoe M; Suzuki Y; Hibi T
    Gut; 2006 Sep; 55(9):1255-62. PubMed ID: 16484504
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study.
    Oshima N; Hiraoka S; Hayashi R; Takahashi S; Ishii M; Hashimoto S; Yashima K; Igawa S; Inokuchi T; Ueno Y; Inaba T; Matsumoto H; Kawashima K; Takami T; Isomoto H; Shiotani A; Tanaka S; Ishihara S
    Inflamm Bowel Dis; 2024 Jul; 30(7):1087-1093. PubMed ID: 37598298
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy.
    Farkas K; Lakatos PL; Szűcs M; Pallagi-Kunstár É; Bálint A; Nagy F; Szepes Z; Vass N; Kiss LS; Wittmann T; Molnár T
    World J Gastroenterol; 2014 Mar; 20(11):2995-3001. PubMed ID: 24659890
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Ulcerative colitis, tacrolimus and mucosa remission].
    Barrio J; Atienza R; Julián-Gómez L; Gil-Simón P; García-Pajares F; Caro-Patón A
    Gastroenterol Hepatol; 2008 Dec; 31(10):711-3. PubMed ID: 19174087
    [No Abstract]   [Full Text] [Related]  

  • 91. Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis.
    Laurent V; Naudé S; Vuitton L; Zallot C; Baumann C; Girard-Gavanier M; Peyrin-Biroulet L
    J Crohns Colitis; 2017 Jun; 11(6):716-723. PubMed ID: 27932450
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
    Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis.
    Lenfant M; Verstockt B; Sabino J; Vermeire S; Ferrante M
    Aliment Pharmacol Ther; 2024 Jan; 59(1):64-70. PubMed ID: 37843544
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.
    Papamichael K; Baert F; Tops S; Assche GV; Rutgeerts P; Vermeire S; Gils A; Ferrante M
    J Crohns Colitis; 2017 Jan; 11(1):53-59. PubMed ID: 27402915
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
    Sandborn WJ; Ferrante M; Bhandari BR; Berliba E; Hibi T; D'Haens GR; Tuttle JL; Krueger K; Friedrich S; Durante M; Arora V; Naegeli AN; Schmitz J; Feagan BG
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):105-115.e14. PubMed ID: 32950748
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases.
    Kawamura H; Matsumoto S; Nakamura N; Miyatani H; Mashima H
    Am J Case Rep; 2017 Apr; 18():405-409. PubMed ID: 28411286
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
    Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Endoscopic and Histological Mucosal Healing in Ulcerative Colitis in the First Year of Diagnosis: Results from a Population-based Inception Cohort from Six Countries in Asia.
    Leung CM; Tang W; Kyaw M; Niamul G; Aniwan S; Limsrivilai J; Wang YF; Ouyang Q; Simadibrata M; Abdullah M; Ong DE; Yu HH; Zhang J; Ching J; Wu JCY; Chan FKL; Sung JJY; Ng SC
    J Crohns Colitis; 2017 Dec; 11(12):1440-1448. PubMed ID: 28961760
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
    Tamaki H; Nakase H; Inoue S; Kawanami C; Itani T; Ohana M; Kusaka T; Uose S; Hisatsune H; Tojo M; Noda T; Arasawa S; Izuta M; Kubo A; Ogawa C; Matsunaka T; Shibatouge M
    Dig Endosc; 2016 Jan; 28(1):67-74. PubMed ID: 26418574
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.
    Naganuma M; Aoyama N; Tada T; Kobayashi K; Hirai F; Watanabe K; Watanabe M; Hibi T
    J Gastroenterol; 2018 Apr; 53(4):494-506. PubMed ID: 28779419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.